Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Réka Király"'
Autor:
Réka Király
Key Selling Points Forest animals try to understand the meaning of tomorrow by reflecting on what they did yesterday and today and staying up all night to watch for when tomorrow begins. Simple dialogue captures children's curiosity and confusion whe
Publikováno v:
Magyar onkologia. 63(2)
The purpose of the study is to report the status of Hungarian radiotherapy (RT). In the 13 centers 84 radiation oncologists, 19 residents, 66 physicists and 231 radiotherapy technologists work, and 40 megavoltage units (38 linear accelerators, 2 coba
Autor:
Réka, Király, Csilla, Pesznyák, Szilvia, Varga, Nhung Anhhong, Nguyen, Tibor, Major, Csaba, Polgár
Publikováno v:
Magyar onkologia. 63(2)
Our goal was to determine the extent of the CTV-PTV margin. Accuracy of patient setup was checked with daily CBCT. Two radiation oncologists performed the image matching independently. The CTV-PTV margin was calculated with the van Herk formula. The
Autor:
András Polyák, Sharmila Banerjee, Pradip Chaudhari, Tapas Das, M. R. A. Pillai, Gyozo A. Janoki, Sudipta Chakraborty, Réka Király, Gergely Jánoki, Domokos Máthé, Gabor Andocs, Lajos Balogh, Julianna Thuróczy
Publikováno v:
Current Radiopharmaceuticals. 9:64-70
177 Lu-EDTMP is currently being investigated as a potential agent for providing palliative care to the patients suffering from bone pain due to metastatic skeletal carcinoma. The present article describes the evaluation of 177Lu-EDTMP complex in four
Autor:
Julianna Thuróczy, András Polyák, Csaba Jakab, Veronika Haász, Sudipta Chakraborty, Gergely Jánoki, Robert Peter Joba, M. R. A. Pillai, Gyozo A. Janoki, Gabriella Dabasi, Zita Pöstényi, Tapas Das, Réka Király, Lajos Balogh
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 29:330-338
The present article describes the preparation, characterization, and biological evaluation of Thulium-170 ((170)Tm) [T1/2 = 128.4 days; Eβmax = 968 keV; Eγ = 84 keV (3.26%)] labeled tin oxide microparticles for its possible use in radiation synovec
Autor:
Zsuzsánna, Zongor, Dalma, Béla, Réka, Király, Gábor, Stelczer, Tibor, Major, Csilla, Pesznyák
Publikováno v:
Magyar onkologia. 60(4)
The purpose of the study was to investigate the physical properties of the EBT2 radiochromic films and define the conditions of its clinical applicability. We irradiated the films with different treatment techniques 3D conformal (3DCRT), intensity-mo
Autor:
András Polyák, John Zaknun, Győző Jánoki, Lajos Balogh, Réka Király, M. R. A. Pillai, Dariusz Pawlak, Domokos Máthé, Teréz Márián
Publikováno v:
Nuclear Medicine and Biology. 37:215-226
Introduction Radionuclide therapy (RNT) is an effective method for bone pain palliation in patients suffering from bone metastasis. Due to the long half-life, easy production and relatively low β− energy, 177 Lu [ T 1/2 =6.73 days, E βmax =497 ke
Autor:
Balázs Kiss, Csilla Pesznyák, Csaba Weisz, István Polgár, Stipan Zelić, Zaránd P, Réka Király
Publikováno v:
Magyar Onkológia. 53:247-251
Absztrakt A jelen kozlemeny celja, hogy bemutassa, milyen kovetelmenyeknek kell, hogy megfeleljen egy szamitogepes retegvizsgalo (CT) keszulek, amennyiben nemcsak diagnosztikus celra szeretnek hasznalni, hanem a besugarzastervezes alapjaul szolgalo C
Publikováno v:
Magyar onkologia. 59(2)
The purpose of the study is to report the status of Hungarian radiotherapy (RT) based on the assessment of treatment data in years 2012 to 2014, available infrastructure, and RT staffing. Between December 2014 and January 2015, a RT questionnaire inc
Autor:
RÉKA, KIRÁLY, CSILLA, PESZNYÁK, SZILVIA, VARGA, NGUYEN ANHHONG NHUNG, TIBOR, MAJOR, CSABA, POLGÁR
Publikováno v:
Magyar Onkologia; 2019, Vol. 63 Issue 2, p110-115, 6p